Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics

被引：104
|
作者：
La Marca, A
Orvieto, R
Giulini, S
Jasonni, VM
Volpe, A
De Leo, V
机构：
[1] Policlin Modena, Inst Obstet & Gynecol, I-41100 Modena, Italy
[2] Univ Siena, I-53100 Siena, Italy
来源：
FERTILITY AND STERILITY | 2004年 / 82卷 / 04期
关键词：
D O I：
10.1016/j.fertnstert.2004.06.001
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The aim of the present study was to examine the relationship between Mullerian-inhibiting substance (MIS) levels and metabolic characteristics in women with polycystic ovary syndrome. Increased ovarian MIS production may exert a paracrine negative control on follicle growth sufficiently to prevent selection of a dominant follicle. (C) 2004 by American Society for Reproductive Medicine.
引用
收藏
页码：970 / 972
页数：3
相关论文
共 50 条
  • [1] Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women
    Cook, CL
    Siow, Y
    Brenner, AG
    Fallat, ME
    FERTILITY AND STERILITY, 2002, 77 (01) : 141 - 146
  • [2] Mullerian-Inhibiting Substance/Anti-Mullerian Hormone as a Predictor of Preterm Birth in Polycystic Ovary Syndrome
    Hsu, Jennifer Y.
    James, Kaitlyn E.
    Bormann, Charles L.
    Donahoe, Patricia K.
    Pepin, David
    Sabatini, Mary E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (11): : 4187 - 4196
  • [3] Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
    Fleming, R
    Harborne, L
    MacLaughlin, DT
    Ling, D
    Norman, J
    Sattar, N
    Seifer, DB
    FERTILITY AND STERILITY, 2005, 83 (01) : 130 - 136
  • [4] Mullerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B
    Chu, MC
    Carmina, E
    Wang, J
    Lobo, RA
    FERTILITY AND STERILITY, 2005, 84 (06) : 1685 - 1688
  • [5] Serum mullerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome
    Siow, Y
    Kives, S
    Hertweck, P
    Perlman, S
    Fallat, ME
    FERTILITY AND STERILITY, 2005, 84 (04) : 938 - 944
  • [6] Relationship between serum mullerian inhibiting substance levels and insulin in women with polycystic ovary syndrome.
    Chilvers, Rebecca A.
    Chakrabarthy, Shilla
    James, Summer
    Ma, Xin
    Nagamani, Manubai
    REPRODUCTIVE SCIENCES, 2008, 15 (02) : 243A - 243A
  • [7] MULLERIAN-INHIBITING SUBSTANCE
    BASHIR, MS
    WELLS, M
    JOURNAL OF PATHOLOGY, 1995, 176 (02): : 109 - 110
  • [8] Mullerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome
    Wang, Jeff G.
    Nakhuda, Gary S.
    Guarnaccia, Michael M.
    Sauer, Mark V.
    Lobo, Rogerio A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (01) : 77 - 78
  • [9] Mutational analysis of the mullerian-inhibiting substance gene and its receptor gene in Japanese women with polycystic ovary syndrome and premature ovarian failure
    Wang, HQ
    Takakura, K
    Takebayashi, K
    Noda, Y
    FERTILITY AND STERILITY, 2002, 78 (06) : 1329 - 1330
  • [10] Mullerian-inhibiting substance in follicular fluid and serum: A comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis
    Fallat, ME
    Siow, Y
    Marra, M
    Cook, C
    Carrillo, A
    FERTILITY AND STERILITY, 1997, 67 (05) : 962 - 965
12345